Berikutnya

Putar otomatis

Managing Avelumab Side Effects in Patients With Merkel Cell Carcinoma

2 Tampilan • 07/17/23
Membagikan
Menanamkan
administrator
administrator
Pelanggan
0

Howard L. Kaufman, MD, FACS, chief surgical officer and associate director for clinical science at Rutgers Cancer Institute of New Jersey, discusses the adverse event profile of avelumab (Bavencio) for patients with Merkel cell carcinoma.

Menampilkan lebih banyak
0 Komentar sort Sortir dengan
Komentar Facebook

Berikutnya

Putar otomatis